Title

COVID-19 Guideline Part 1: Treatment and Management

Authoring Organization

Publication Month/Year

June 26, 2023

Last Updated Month/Year

February 14, 2024

Document Type

Guideline

Country of Publication

US

Document Objectives

There are many pharmacologic therapies that are being used or considered for treatment of coronavirus disease 2019 (COVID-19). There is a need for frequently updated practice guidelines on their use, based on critical evaluation of rapidly emerging literature

Inclusion Criteria

Male, Female, Adult, Older adult

Health Care Settings

Ambulatory, Hospital

Intended Users

Epidemiology infection prevention, nurse, nurse practitioner, health systems pharmacist, physician, physician assistant

Scope

Treatment, Management

Diseases/Conditions (MeSH)

D017934 - Coronavirus

Keywords

Coronavirus, covid-19, COVID

Supplemental Methodology Resources

Data Supplement, Evidence Tables